Telix Pharmaceuticals | TLX - Umsatzerlöse

Aktienkurs
12.50
Täglich Wechseln
-0.30 -2.34%
Monatlich
35.87%
Jährlich
-56.79%
Q1 Prognose
12.48




Der Umsatz Veränderung Datum
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Integral Diagnostics AUD 238.44M 7.19M 2024-06
Mayne Pharma AUD 212.07M 17.03M 2025-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Mesoblast USD 51.34M 38.14M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Pacific Edge NZD 5.94M 4.95M 2025-12
Paradigm Biopharmaceuticals AUD 284.06K 292.06K 2025-12
Polynovo AUD 70.33M 35.75M 2025-12
PYC Therapeutics AUD 11.04M 2.44M 2025-12
Ramsay Health Care AUD 9.34B 82.2M 2025-12
ResMed USD 1.42B 87.23M 2025-12
Sonic Healthcare AUD 5.45B 470M 2025-12